GO:0090304 | nucleic acid metabolic process | 20.83% (30/144) | 1.52 | 0.0 | 0.000137 |
GO:0046483 | heterocycle metabolic process | 25.0% (36/144) | 1.19 | 2e-06 | 0.000242 |
GO:0070585 | protein localization to mitochondrion | 4.86% (7/144) | 3.68 | 1e-06 | 0.000249 |
GO:0072655 | establishment of protein localization to mitochondrion | 4.86% (7/144) | 3.68 | 1e-06 | 0.000249 |
GO:0006139 | nucleobase-containing compound metabolic process | 23.61% (34/144) | 1.31 | 0.0 | 0.000278 |
GO:0044424 | intracellular part | 87.5% (126/144) | 0.32 | 1e-06 | 0.000306 |
GO:0006626 | protein targeting to mitochondrion | 4.86% (7/144) | 3.71 | 1e-06 | 0.000328 |
GO:0006396 | RNA processing | 11.11% (16/144) | 1.98 | 3e-06 | 0.000471 |
GO:0044464 | cell part | 91.67% (132/144) | 0.25 | 4e-06 | 0.000495 |
GO:0034641 | cellular nitrogen compound metabolic process | 25.0% (36/144) | 1.11 | 6e-06 | 0.000649 |
GO:0006260 | DNA replication | 6.25% (9/144) | 2.73 | 9e-06 | 0.000881 |
GO:0006259 | DNA metabolic process | 10.42% (15/144) | 1.95 | 9e-06 | 0.000909 |
GO:0006839 | mitochondrial transport | 4.86% (7/144) | 3.17 | 1.4e-05 | 0.001088 |
GO:0006725 | cellular aromatic compound metabolic process | 25.0% (36/144) | 1.05 | 1.3e-05 | 0.001158 |
GO:0032259 | methylation | 8.33% (12/144) | 2.17 | 1.7e-05 | 0.001159 |
GO:0043414 | macromolecule methylation | 8.33% (12/144) | 2.17 | 1.7e-05 | 0.001159 |
GO:0007020 | microtubule nucleation | 3.47% (5/144) | 3.86 | 2.5e-05 | 0.001631 |
GO:0016070 | RNA metabolic process | 13.89% (20/144) | 1.47 | 3.5e-05 | 0.002199 |
GO:0044428 | nuclear part | 8.33% (12/144) | 2.0 | 5.2e-05 | 0.002767 |
GO:0018193 | peptidyl-amino acid modification | 6.94% (10/144) | 2.26 | 5e-05 | 0.002822 |
GO:0016569 | covalent chromatin modification | 6.94% (10/144) | 2.27 | 4.8e-05 | 0.002849 |
GO:0018205 | peptidyl-lysine modification | 6.25% (9/144) | 2.34 | 7.8e-05 | 0.004 |
GO:1901360 | organic cyclic compound metabolic process | 24.31% (35/144) | 0.95 | 8.8e-05 | 0.004301 |
GO:0006325 | chromatin organization | 7.64% (11/144) | 2.0 | 0.000106 | 0.004556 |
GO:0008380 | RNA splicing | 5.56% (8/144) | 2.49 | 9.9e-05 | 0.004616 |
GO:0006261 | DNA-dependent DNA replication | 4.86% (7/144) | 2.71 | 0.000103 | 0.004645 |
GO:0051607 | defense response to virus | 4.17% (6/144) | 2.93 | 0.000144 | 0.005979 |
GO:0007276 | gamete generation | 2.08% (3/144) | 4.65 | 0.000227 | 0.007272 |
GO:0006807 | nitrogen compound metabolic process | 31.94% (46/144) | 0.72 | 0.000221 | 0.007289 |
GO:0031047 | gene silencing by RNA | 4.86% (7/144) | 2.57 | 0.000189 | 0.00731 |
GO:0043170 | macromolecule metabolic process | 29.17% (42/144) | 0.78 | 0.000206 | 0.007443 |
GO:0032501 | multicellular organismal process | 15.28% (22/144) | 1.2 | 0.00022 | 0.007466 |
GO:0044260 | cellular macromolecule metabolic process | 24.31% (35/144) | 0.89 | 0.000186 | 0.007472 |
GO:0016043 | cellular component organization | 20.14% (29/144) | 1.0 | 0.000214 | 0.007503 |
GO:0016458 | gene silencing | 5.56% (8/144) | 2.34 | 0.000201 | 0.007519 |
GO:0042023 | DNA endoreduplication | 3.47% (5/144) | 3.11 | 0.000294 | 0.009157 |
GO:0044786 | cell cycle DNA replication | 3.47% (5/144) | 3.1 | 0.000306 | 0.009288 |
GO:0009067 | aspartate family amino acid biosynthetic process | 3.47% (5/144) | 3.05 | 0.00036 | 0.010634 |
GO:0009615 | response to virus | 4.17% (6/144) | 2.67 | 0.000382 | 0.010995 |
GO:0016570 | histone modification | 5.56% (8/144) | 2.13 | 0.000524 | 0.014707 |
GO:0071840 | cellular component organization or biogenesis | 20.14% (29/144) | 0.89 | 0.000724 | 0.0198 |
GO:0016571 | histone methylation | 4.86% (7/144) | 2.24 | 0.000758 | 0.02026 |
GO:0009640 | photomorphogenesis | 4.17% (6/144) | 2.46 | 0.000834 | 0.020347 |
GO:0009066 | aspartate family amino acid metabolic process | 3.47% (5/144) | 2.79 | 0.000821 | 0.020462 |
GO:0006479 | protein methylation | 4.86% (7/144) | 2.22 | 0.000806 | 0.02056 |
GO:0008213 | protein alkylation | 4.86% (7/144) | 2.22 | 0.000806 | 0.02056 |
GO:1901607 | alpha-amino acid biosynthetic process | 5.56% (8/144) | 2.02 | 0.000878 | 0.020961 |
GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity | 1.39% (2/144) | 5.42 | 0.000946 | 0.021236 |
GO:0061505 | DNA topoisomerase II activity | 1.39% (2/144) | 5.42 | 0.000946 | 0.021236 |
GO:0009791 | post-embryonic development | 6.94% (10/144) | 1.73 | 0.000927 | 0.021659 |
GO:0006913 | nucleocytoplasmic transport | 3.47% (5/144) | 2.7 | 0.001087 | 0.02345 |
GO:0051169 | nuclear transport | 3.47% (5/144) | 2.7 | 0.001087 | 0.02345 |
GO:0048609 | multicellular organismal reproductive process | 4.17% (6/144) | 2.34 | 0.001274 | 0.02696 |
GO:0051276 | chromosome organization | 4.17% (6/144) | 2.33 | 0.001302 | 0.027059 |
GO:0034968 | histone lysine methylation | 4.17% (6/144) | 2.32 | 0.001361 | 0.02777 |
GO:0018022 | peptidyl-lysine methylation | 4.17% (6/144) | 2.31 | 0.001392 | 0.02788 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 3.47% (5/144) | 2.59 | 0.001493 | 0.027924 |
GO:0043226 | organelle | 72.92% (105/144) | 0.26 | 0.001483 | 0.028208 |
GO:0043231 | intracellular membrane-bounded organelle | 72.22% (104/144) | 0.27 | 0.001461 | 0.028265 |
GO:0043229 | intracellular organelle | 72.92% (105/144) | 0.26 | 0.001458 | 0.028704 |
GO:0043227 | membrane-bounded organelle | 72.22% (104/144) | 0.27 | 0.001577 | 0.029006 |
GO:0000278 | mitotic cell cycle | 3.47% (5/144) | 2.57 | 0.001621 | 0.02934 |
GO:0000226 | microtubule cytoskeleton organization | 4.17% (6/144) | 2.26 | 0.001652 | 0.029429 |
GO:0009086 | methionine biosynthetic process | 2.78% (4/144) | 2.97 | 0.001743 | 0.030565 |
GO:0009616 | virus induced gene silencing | 2.78% (4/144) | 2.93 | 0.001947 | 0.032607 |
GO:0052018 | modulation by symbiont of RNA levels in host | 2.78% (4/144) | 2.93 | 0.001947 | 0.032607 |
GO:0052249 | modulation of RNA levels in other organism involved in symbiotic interaction | 2.78% (4/144) | 2.93 | 0.001947 | 0.032607 |
GO:0043412 | macromolecule modification | 14.58% (21/144) | 0.98 | 0.002102 | 0.03276 |
GO:0032991 | protein-containing complex | 11.81% (17/144) | 1.13 | 0.002053 | 0.032909 |
GO:0006555 | methionine metabolic process | 2.78% (4/144) | 2.9 | 0.002092 | 0.033054 |
GO:0098586 | cellular response to virus | 2.78% (4/144) | 2.91 | 0.002018 | 0.033305 |
GO:0007389 | pattern specification process | 4.86% (7/144) | 1.99 | 0.002052 | 0.033363 |
GO:0006304 | DNA modification | 3.47% (5/144) | 2.39 | 0.002754 | 0.035118 |
GO:0010267 | production of ta-siRNAs involved in RNA interference | 2.78% (4/144) | 2.79 | 0.002744 | 0.03539 |
GO:0035821 | modification of morphology or physiology of other organism | 2.78% (4/144) | 2.79 | 0.002744 | 0.03539 |
GO:0044003 | modification by symbiont of host morphology or physiology | 2.78% (4/144) | 2.79 | 0.002744 | 0.03539 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 2.78% (4/144) | 2.79 | 0.002744 | 0.03539 |
GO:0006305 | DNA alkylation | 3.47% (5/144) | 2.42 | 0.002565 | 0.03553 |
GO:0006306 | DNA methylation | 3.47% (5/144) | 2.42 | 0.002565 | 0.03553 |
GO:0051302 | regulation of cell division | 2.08% (3/144) | 3.47 | 0.002535 | 0.036007 |
GO:0051567 | histone H3-K9 methylation | 3.47% (5/144) | 2.42 | 0.002504 | 0.03602 |
GO:0061647 | histone H3-K9 modification | 3.47% (5/144) | 2.42 | 0.002504 | 0.03602 |
GO:0003916 | DNA topoisomerase activity | 1.39% (2/144) | 4.78 | 0.002352 | 0.036145 |
GO:0000151 | ubiquitin ligase complex | 3.47% (5/144) | 2.44 | 0.002385 | 0.036167 |
GO:0008652 | cellular amino acid biosynthetic process | 5.56% (8/144) | 1.76 | 0.002644 | 0.036173 |
GO:0007017 | microtubule-based process | 4.17% (6/144) | 2.15 | 0.00242 | 0.036209 |
GO:0044728 | DNA methylation or demethylation | 3.47% (5/144) | 2.4 | 0.00269 | 0.036366 |
GO:0010629 | negative regulation of gene expression | 6.25% (9/144) | 1.65 | 0.002483 | 0.036656 |
GO:0072594 | establishment of protein localization to organelle | 5.56% (8/144) | 1.72 | 0.003181 | 0.0401 |
GO:0033365 | protein localization to organelle | 5.56% (8/144) | 1.71 | 0.003306 | 0.041218 |
GO:0002252 | immune effector process | 4.17% (6/144) | 2.06 | 0.003371 | 0.04156 |
GO:0040029 | regulation of gene expression, epigenetic | 4.17% (6/144) | 2.05 | 0.003431 | 0.041839 |
GO:0051701 | interaction with host | 2.78% (4/144) | 2.68 | 0.003631 | 0.043808 |
GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 2.78% (4/144) | 2.67 | 0.00374 | 0.044645 |
GO:0016925 | protein sumoylation | 1.39% (2/144) | 4.42 | 0.0039 | 0.046065 |
GO:0004635 | phosphoribosyl-AMP cyclohydrolase activity | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0004636 | phosphoribosyl-ATP diphosphatase activity | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0032206 | positive regulation of telomere maintenance | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:1904358 | positive regulation of telomere maintenance via telomere lengthening | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0030894 | replisome | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0042555 | MCM complex | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0043601 | nuclear replisome | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0033477 | S-methylmethionine metabolic process | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0033528 | S-methylmethionine cycle | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0019211 | phosphatase activator activity | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0080009 | mRNA methylation | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0004164 | diphthine synthase activity | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0006448 | regulation of translational elongation | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0017182 | peptidyl-diphthamide metabolic process | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0018202 | peptidyl-histidine modification | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:1900247 | regulation of cytoplasmic translational elongation | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:2000765 | regulation of cytoplasmic translation | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0006907 | pinocytosis | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0047793 | cycloeucalenol cycloisomerase activity | 0.69% (1/144) | 7.59 | 0.005207 | 0.048686 |
GO:0044422 | organelle part | 18.75% (27/144) | 0.74 | 0.005282 | 0.048979 |